World news, news around town, tech update 3
Ad
Tuesday, 5 June 2018
AbbVie's rheumatoid arthritis drug succeeds in late-stage study
(Reuters) - Abbvie Inc said on Tuesday its experimental drug upadacitinib met the main goals of a late-stage study in patients with moderate-to-severe rheumatoid arthritis.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment